Gerresheimer AG (GXI) Given Average Rating of “Hold” by Analysts
Gerresheimer AG (ETR:GXI) has received an average recommendation of “Hold” from the eleven research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is €72.64 ($86.48).
A number of equities research analysts have weighed in on the stock. Kepler Capital Markets set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a “sell” rating in a research note on Friday, November 3rd. Deutsche Bank set a €64.00 ($76.19) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Friday. Goldman Sachs Group set a €69.50 ($82.74) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Thursday, October 12th. Independent Research set a €68.00 ($80.95) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research note on Wednesday, October 11th. Finally, J P Morgan Chase & Co set a €99.40 ($118.33) target price on shares of Gerresheimer and gave the company a “buy” rating in a research note on Wednesday, October 11th.
Shares of Gerresheimer (ETR:GXI) opened at €67.18 ($79.98) on Monday. Gerresheimer has a 12 month low of €59.97 ($71.39) and a 12 month high of €78.25 ($93.15).
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.